Michael B. Elefante’s Novo Nordisk NVO Stock Holding History

Michael B. Elefante’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$466K	Hold	22,000	–	–	0.51%	47
2014 Q3	$524K	Sell	22,000 -3,500	-14%	-$80.5K	0.23%	61
2014 Q2	$589K	Sell	25,500 -3,000	-11%	-$66.2K	0.25%	60
2014 Q1	$651K	Sell	28,500 -2,000	-7%	-$42.6K	0.28%	54
2013 Q4	$564K	Hold	30,500	–	–	0.26%	57
2013 Q3	$516K	Sell	30,500 -2,000	-6%	-$33.6K	0.26%	57
2013 Q2	$504K	Buy	+32,500	New	+$541K	0.27%	54

Other funds holding NVO

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Michael B. Elefante's NVO Position: Q4 2014 in Review

Michael B. Elefante held its Novo Nordisk (NVO) position steady in Q4 2014 at 22,000 shares worth $466K. The position accounts for 0.51% of the portfolio, ranked #47.

Michael B. Elefante first reported a position in NVO in Q2 2013 and has held it in 7 quarters since. The position peaked at $651K in Q1 2014. 501 funds tracked by Wall St. Rank hold NVO as of Q4 2014.

Michael B. Elefante held 22,000 shares of Novo Nordisk worth $466K as of Q4 2014.
Michael B. Elefante left its Novo Nordisk share count unchanged in Q4 2014.
Novo Nordisk made up 0.51% of Michael B. Elefante's portfolio in Q4 2014, its #47 holding.
Michael B. Elefante first reported a position in Novo Nordisk in Q2 2013 and has held it in 7 quarters since.
Michael B. Elefante's Novo Nordisk position peaked at $651K in Q1 2014.
501 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2014.

Based on Michael B. Elefante's 13F filing for Q4 2014, filed 13 Feb 2015.